Vanda Jorgetti Selected Research

Minerals

1/2022	Iron-based phosphorus chelator: Risk of iron deposition and action on bone metabolism in uremic rats.
4/2021	High prevalence of biochemical disturbances of chronic kidney disease - mineral and bone disorders (CKD-MBD) in a nation-wide peritoneal dialysis cohort: are guideline goals too hard to achieve?
3/2020	Digital radiography as an alternative method in the evaluation of bone density in uremic rats.
1/2020	Renal osteodystrophy and clinical outcomes: data from the Brazilian Registry of Bone Biopsies - REBRABO.
1/2019	Comparison of clinical, biochemical and histomorphometric analysis of bone biopsies in dialysis patients with and without fractures.
1/2018	Persistent hyperparathyroidism as a risk factor for long-term graft failure: the need to discuss indication for parathyroidectomy.
1/2018	Effect of cross-linked chitosan iron (III) on vascular calcification in uremic rats.
1/2017	Fragility Fracture Incidence in Chronic Obstructive Pulmonary Disease (COPD) Patients Associates With Nanoporosity, Mineral/Matrix Ratio, and Pyridinoline Content at Actively Bone-Forming Trabecular Surfaces.
1/2017	Predictive Factors of One-Year Mortality in a Cohort of Patients Undergoing Urgent-Start Hemodialysis.
1/2017	The complexity of chronic kidney disease-mineral and bone disorder across stages of chronic kidney disease.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Vanda Jorgetti Research Topics

Disease

39	Chronic Renal Insufficiency 01/2022 - 01/2007
21	Chronic Kidney Disease-Mineral and Bone Disorder (Renal Rickets) 04/2021 - 03/2003
16	Secondary Hyperparathyroidism 02/2021 - 04/2003
12	Bone Diseases (Bone Disease) 01/2022 - 10/2004
10	Hyperparathyroidism 04/2021 - 03/2007
9	Bone Resorption 12/2021 - 12/2006
9	Vascular Calcification 01/2018 - 01/2008
8	Hyperphosphatemia 01/2018 - 12/2004
7	Osteoporosis 01/2020 - 10/2004
6	Chronic Kidney Failure (Chronic Renal Failure) 07/2020 - 04/2003
5	Inflammation (Inflammations) 01/2021 - 04/2005
4	Uremia 03/2020 - 04/2005
4	Cardiovascular Diseases (Cardiovascular Disease) 01/2017 - 12/2004
3	Kidney Diseases (Kidney Disease) 04/2021 - 01/2013
3	Hypocalcemia 01/2017 - 07/2010
3	Body Weight (Weight, Body) 01/2016 - 12/2004
3	Renal Insufficiency (Renal Failure) 05/2014 - 07/2010
3	Atherosclerosis 02/2012 - 04/2005
3	Metabolic Bone Diseases (Osteopenia) 12/2010 - 08/2008
2	Fibrosis (Cirrhosis) 01/2021 - 11/2013
2	Thyrotoxicosis 01/2019 - 11/2003
2	Bone Fractures (Bone Fracture) 01/2019 - 10/2004
2	Pain (Aches) 01/2018 - 01/2016
2	Chronic Obstructive Pulmonary Disease (COPD) 01/2017 - 09/2010
2	Hypoparathyroidism 09/2016 - 01/2013
2	Hypercalcemia (Milk Alkali Syndrome) 01/2016 - 10/2004
2	Hypercalciuria 07/2014 - 09/2008
2	Hypertension (High Blood Pressure) 01/2013 - 04/2012
2	Postmenopausal Osteoporosis 03/2011 - 10/2004
1	Iron Overload 01/2022
1	Diabetes Mellitus 07/2020
1	Osteitis 01/2020
1	Osteomalacia 01/2020
1	Tibial Fractures (Fracture, Tibial) 01/2020
1	Infections 01/2019
1	HIV Infections (HIV Infection) 01/2019
1	Dementia (Dementias) 04/2018
1	Arteriovenous Fistula 01/2017
1	Lupus Nephritis 01/2017
1	Acidosis 03/2016
1	Familial Hypophosphatemic Rickets (X-Linked Hypophosphatemia) 01/2016
1	Sleep Wake Disorders 01/2016
1	Restless Legs Syndrome (Restless Legs) 01/2016
1	Nephrocalcinosis 01/2016

Drug/Important Bio-Agent (IBA)

29	MineralsIBA 01/2022 - 11/2007
19	Parathyroid Hormone (Parathormone)IBA 02/2021 - 10/2004
15	Phosphates (Orthophosphate)IBA 01/2022 - 01/2007
13	CalciumIBA 03/2020 - 04/2003
8	Phosphorus (Red Phosphorus)IBA 01/2022 - 04/2003
8	Vitamin D FDA LinkGeneric 07/2019 - 04/2003
6	Biomarkers (Surrogate Marker)IBA 04/2021 - 04/2005
6	CreatinineIBA 03/2020 - 02/2011
6	Fibroblast Growth Factor-23IBA 03/2020 - 01/2011
5	Sevelamer (RenaGel)FDA Link 01/2018 - 01/2008
4	IronIBA 01/2022 - 10/2004
4	Proteins (Proteins, Gene)FDA Link 01/2021 - 02/2005
4	Alkaline PhosphataseIBA 03/2020 - 05/2015
4	ApolipoproteinsIBA 08/2015 - 07/2010
4	GlucocorticoidsIBA 01/2014 - 10/2004
3	Adenine FDA LinkGeneric 03/2020 - 05/2014
3	AluminumIBA 01/2020 - 10/2004
3	OsteoprotegerinIBA 01/2019 - 01/2008
3	Zoledronic Acid (Zometa)FDA Link 01/2018 - 10/2004
3	LigandsIBA 04/2017 - 01/2008
2	Calcium Carbonate (Limestone)FDA Link 01/2022 - 01/2018
2	ChitosanIBA 01/2022 - 01/2018
2	SmokeIBA 12/2021 - 01/2020
2	Proliferating Cell Nuclear Antigen (PCNA)IBA 01/2021 - 09/2005
2	Ethanol (Ethyl Alcohol)IBA 07/2020 - 03/2004
2	C-Reactive ProteinIBA 07/2019 - 01/2017
2	Diphosphonates (Bisphosphonates)IBA 01/2019 - 10/2004
2	RANK LigandIBA 01/2019 - 09/2008
2	Receptor Activator of Nuclear Factor-kappa B (TRANCE-R)IBA 01/2019 - 01/2008
2	hydroxide ionIBA 06/2014 - 01/2007
2	Tetracycline (Achromycin)FDA LinkGeneric 11/2013 - 09/2010
2	calcium acetate (Phoslo)FDA LinkGeneric 10/2013 - 07/2009
2	CateninsIBA 01/2013 - 08/2012
2	Hormones (Hormone)IBA 08/2012 - 02/2010
2	Insulin-Like Growth Factor I (IGF-1)IBA 07/2009 - 02/2005
2	Calcitriol (Calcijex)FDA LinkGeneric 06/2009 - 04/2003
1	Chelating AgentsIBA 01/2022
1	Thiobarbituric Acid Reactive SubstancesIBA 12/2021
1	Polytetrafluoroethylene (Teflon)FDA Link 03/2020
1	HomocysteineIBA 07/2019
1	Tenofovir (Viread)FDA Link 01/2019
1	Triiodothyronine (Liothyronine)FDA LinkGeneric 01/2019
1	ChitinIBA 01/2018
1	Eosine Yellowish-(YS) (Eosin)IBA 01/2018
1	Hematoxylin (Haematoxylon)IBA 01/2018
1	PolymersIBA 01/2018
1	25-hydroxyvitamin DIBA 07/2017
1	Tartrate-Resistant Acid PhosphataseIBA 04/2017
1	pyridinolineIBA 01/2017
1	Bicarbonates (Hydrogen Carbonate)IBA 03/2016
1	Protons (Proton)IBA 03/2016
1	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 03/2016

Therapy/Procedure

18	Parathyroidectomy 04/2021 - 03/2004
15	Renal Dialysis (Hemodialysis) 04/2021 - 04/2005
7	Therapeutics 10/2016 - 03/2004
3	Peritoneal Dialysis 04/2021 - 11/2014